InnovAge Holding (INNV) risk factors
Item 1A of every InnovAge Holding Corp. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2026 10-K risk factors38 risks5 new8 dropped18 reworded
Government funding concentration is more prominent, with Colorado and California producing 70.2% of fiscal 2026 capitation revenue.
Filed Sep 09, 2026 - FY2025 10-K risk factors41 risks8 new14 dropped22 reworded
InnovAge added risks regarding a new pharmacy business acquisition, credit agreement covenants, and Nasdaq listing requirements.
Filed Sep 09, 2025 - FY2024 10-K risk factors47 risks
InnovAge relies almost entirely on fixed PMPM government capitation payments through Medicare and Medicaid PACE programs. Operations face high geographic concentration in Colorado and complex healthcare regulatory compliance risks. Growth depends heavily on recruitment, retention, and strategic acquisitions following past sanctions.
Filed Sep 10, 2024